Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - Stryker's stock rises after announcing a partnership with CMR Surgical to enter the soft tissue robotics market

BUZZ - Stryker's stock rises after announcing a partnership with CMR Surgical to enter the soft tissue robotics market

路透社路透社2026/10/12 16:21
Show original

- ** Medical device manufacturer Stryker (SYK.N) shares rose over 1% to $280.87

** The company has established a strategic alliance with UK-based CMR Surgical to expand its robotic-assisted surgery business

** SYK will invest about $400 million to purchase preferred shares of CMR, entering the fast-growing soft tissue robotics market

** SYK becomes the exclusive US distributor of CMR's Versius surgical robot; CMR will continue to handle R&D and sales outside the US

** The deal includes an exclusive option for SYK to acquire all remaining shares of CMR in the future

** Out of 30 brokerages, 25 gave SYK a “buy” or higher rating, 5 a “hold”; median target price is $367.50—data compiled by LSEG

** Including today’s movement, shares are down 20% year-to-date


(To assist non-English speakers, Reuters automatically translates its reports into several other languages. Because automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation and provides it for readers’ convenience only. Reuters assumes no responsibility for any damage or loss caused by the use of automated translation.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56

Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go

Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.

智通财经•2026/10/13 01:36